Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma
Jaime O Claudio, A Keith Stewart
Current Hematology Reports
|
December 30, 2003
Insights from the gene expression profiling of multiple myeloma
Jaime O Claudio, Esther Masih-Khan, A Keith Stewart
The Journal of Rheumatology
|
September 12, 2008
The prevalence and accuracy of self-reported history of 11 autoimmune diseases
Glinda S Cooper, Joan Wither, Tamara McKenzie, et al.
BMC Medical Genomics
|
March 19, 2013
Cancer patient perceptions on the ethical and legal issues related to biobanking
Zubin Master, Jaime O Claudio, Christen Rachul, et al.
Rheumatology (Oxford, England)
|
August 3, 2010
Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents
Glinda S Cooper, Joan Wither, Sasha Bernatsky, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
August 28, 2025
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
The Journal of Experimental Medicine
|
September 24, 2004
The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades
Yuan Xiao Zhu, Sally Benn, Zhi Hua Li, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
August 28, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
September 2, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Blood
|
July 20, 2006
MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma
Esther Masih-Khan, Suzanne Trudel, Carla Heise, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma
Jaime O Claudio, A Keith Stewart
Current Hematology Reports
|
December 30, 2003
Insights from the gene expression profiling of multiple myeloma
Jaime O Claudio, Esther Masih-Khan, A Keith Stewart
The Journal of Rheumatology
|
September 12, 2008
The prevalence and accuracy of self-reported history of 11 autoimmune diseases
Glinda S Cooper, Joan Wither, Tamara McKenzie, et al.
BMC Medical Genomics
|
March 19, 2013
Cancer patient perceptions on the ethical and legal issues related to biobanking
Zubin Master, Jaime O Claudio, Christen Rachul, et al.
Rheumatology (Oxford, England)
|
August 3, 2010
Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents
Glinda S Cooper, Joan Wither, Sasha Bernatsky, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
August 28, 2025
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
The Journal of Experimental Medicine
|
September 24, 2004
The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades
Yuan Xiao Zhu, Sally Benn, Zhi Hua Li, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
August 28, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique
|
September 2, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences
Verna Cheung, Melanie Powis, Jaime O Claudio, et al.
Blood
|
July 20, 2006
MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma
Esther Masih-Khan, Suzanne Trudel, Carla Heise, et al.
Page
of 2